Alternative data discontinuations in 2023: for the record
We highlight the key drivers behind these discontinuations, summarise datasets that terminated and discuss some risk factors and market trends to consider throughout 2024.
-
-
Banks vs fintechs: Tracking market share with technographic data
Alternative data that analyses tech stacks can be a useful way to benchmark companies, especially in sectors at risk of disruption. Below, we summarise a paper that uses banks’ technographic profiles as an indicator for loan concentration and market share during Covid-19. -
10 data products that might not survive 2024
After record discontinuations in 2023, we take a look at 10 data offerings that might join the growing list of discontinuations in 2024. -
Location data reckoning: Ripple effects of FTC’s recent activity
Location data has been a riskier category in the past couple of years, but with the FTC announcing charges against Outlogic, formerly X-Mode Social, on January 9th and InMarket on January 17th, it started 2024 with a bang. -
2023 DDQ wrap-up – Key factors in data vendor risk (Part 1)
Assessing vendor compliance means thinking about vendors in the context of the space they exist in. In this report, we look at how vendors of different sizes answered six key questions from our DDQ and the implications for buyers. -
2024 Factbook: Emerging alt data markets
Our proprietary metadata reveals how alt data is developing in new markets around the world, highlighting not only the most popular datasets in each region but also looking at trends in pricing and adoption. -
How climate news affects investment returns
We summarise a study that investigates the relationship between unexpected climate news and equity performance, aiming to quantify climate beta. -
The Signal, January 2024: New Year predictions, Christmas frugality and bleak employment indicators
This month’s alternative data insights include vendors’ predictions for 2024, consumer Christmas trends and signs of a challenging job market. -
Consumer transaction data: A bird’s-eye view…revisited
We revisit the ever-changing world of consumer transaction data, exploring developments in e-receipts, point-of-sale and credit and debit card data. -
Money meets medicine: The private equity prescription for alternative healthcare data
While Ozempic stole 2023’s healthcare headlines, the sector also saw an uptick in private equity interest. In this intelligence piece we explore key areas where alternative data can offer additional insights.